---
$id: https://graph.org.ai/products/commodity/51131643
$type: Product
source: UNSPSC
code: "51131643"
title: "Indobufen"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Indobufen

**UNSPSC Code**: 51131643
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C18H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6T9949G4LZ, chemically known as 4-(1,3-dihydro-1-oxo-2h-isoindol-2-yl)-alpha-ethylbenzeneacetic acid but generally known as indobufen, which bears US NIH Compound Identifier 107641. European Medicines Agency schedules Indobufen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08176MIG. The term INDOBUFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules indobufen in its Anatomical Therapeutic Chemical (ATC) Classification. INDOBUFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule indobufen under HS 29337900 and SITC 51561. As of Q4 2014, INDOBUFEN remains the US FDA Preferred Term for this commodity. Indobufen bears US NLM identifiers UMLS ID C0063479 and NCI Concept Code C83800. SMILES: O=C1N(CC2C1CCCC2)C1CCC(C(CC)C(=O)O)CC1.

